Status:
WITHDRAWN
Dyslipidemia Treatment in Thailand and Cardiovascular Outcomes
Lead Sponsor:
AstraZeneca
Conditions:
Dyslipidemia
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to establish the proportion of patients on lipid-lowering pharmacological treatment (statin or combination) reaching the LDL-C goals according to the updated 2004 National...
Detailed Description
MC MD
Eligibility Criteria
Inclusion
- Provision of subject informed consent, Female or male aged = 18 years
- Patients eligible for treatment of dyslipidemia with statins, according to the current guidelines NCEP ATPIII about Dyslipidemias and Atherosclerosis Prevention Receiving lipid-lowering drug treatment for at least 15 days.
Exclusion
- Involvement in the planning and conduct of the study (applies to either AstraZeneca staff or staff at the study site).
- Previous enrolment or randomisation of treatment in the present study
- Participation in a clinical study during the last 90 days
Key Trial Info
Start Date :
March 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2013
Estimated Enrollment :
1064 Patients enrolled
Trial Details
Trial ID
NCT01265836
Start Date
March 1 2011
End Date
March 1 2013
Last Update
April 12 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.